Welcome to the NeurologyLive Mind Moments podcast. In this episode, Daniel Lowenstein, MD, professor of neurology and executive vice chancellor and provost at the University of California, San Francisco, shares the latest research updates showing how the gut microbiome plays a role in epilepsy, and how altering the gut microbiota may prove to be a very promising therapeutic option in the future. For more on epilepsy and other neurology topics, visit NeurologyLive.com. Thanks for listening.

Welcome to the NeurologyLive Mind Moments podcast. 

In this episode, Amaal Starling, MD, assistant professor of neurology at Mayo Clinic Scottsdale, shares her experiences with a number of new migraine drugs and devices and the impact that more options will have on clinical practice.

For more on migraine and other neurology topics, visit NeurologyLive.com. Thanks for listening. 

Welcome to the NeurologyLive Mind Moments podcast. 

In this episode, Fred Rincon, MD, MSc, Chief of cerebrovascular disease at the Farber Institute for Neuroscience and associate professor of neurology and neurological surgery at Thomas Jefferson University in Philadelphia, reflects on the current state of vascular neurology and how technology can play a major role in closing the gaps in stroke care. 

For more on stroke and other neurology topics, visit NeurologyLive.com. Thanks for listening. 

Welcome to the NeurologyLive Mind Moments podcast. 

In this episode, Reisa Sperling, MD, Director of the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital and Massachusetts General Hospital, and Professor of Neurology at Harvard Medical School, shares her thoughts on the amyloid hypothesis, and discusses the future of Alzheimer disease research focused on early detection and intervention. 

For more on Alzheimer disease, dementia, and other neurology topics, visit NeurologyLive.com. Thanks for listening. 

Welcome to the NeurologyLive Mind Moments podcast. 

In this episode, Anup Patel, MD, Section Chief of Pediatric Neurology at Nationwide Children’s and Associate Professor of Clinical Pediatrics and Neurology at The Ohio State University College of Medicine, discusses the current state of cannabidiol (CBD) in the US, and why increasing public access to the molecule via legalized marijuana is becoming a big problem for clinicians treating patients with serious neurologic disorders. 

For more on CBD, epilepsy, and other neurology topics, visit NeurologyLive.com. Thanks for listening.